APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Growth and Trends Forecast to 2032

28 December 202592 pages

Choose your research edition.

Industry ResearchGranulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) include Nobelpharma, Partner Therapeutics, Guangzhou Baiyunshan Pharmaceutical, Harbin Pharmaceutical Group, Hainan Unipul Pharmaceutical, North China Pharmaceutical, Amoytop Biotech and Changchun GeneScience Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Company

Nobelpharma

Partner Therapeutics

Guangzhou Baiyunshan Pharmaceutical

Harbin Pharmaceutical Group

Hainan Unipul Pharmaceutical

North China Pharmaceutical

Amoytop Biotech

Changchun GeneScience Pharmaceutical

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Type

Injection

Inhalation

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Application

Cancer Treatment Support

Infectious Disease Treatment

Proteinosis Autoimmune Pulmonary Alveolar

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Inhalation Table 3. Major Company of Other Table 4. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type (2021-2026) Table 9. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2026) & (US$/Unit) Table 10. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 11. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type (2027-2032) Table 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2027-2032) & (US$/Unit) Table 15. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 16. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 18. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 22. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (US$ Million) Table 25. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends Table 26. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers Table 27. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges Table 28. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints Table 29. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Company (2021-2026) Table 31. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Company (2021-2026) & (K Units) Table 32. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Company (2021-2026) Table 33. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Major Company Production Sites and Headquarters Table 36. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Company, Product Type & Application Table 37. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026) & (K Units) Table 42. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Region (2021-2026) Table 45. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2027-2032) & (K Units) Table 47. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Region (2027-2032) Table 50. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 53. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application (2021-2026) Table 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application (2027-2032) Table 61. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2027-2032) & (US$/Unit) Table 62. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 63. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 65. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 69. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (US$ Million) Table 72. Nobelpharma Company Information Table 73. Nobelpharma Business Overview Table 74. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 76. Nobelpharma Recent Development Table 77. Partner Therapeutics Company Information Table 78. Partner Therapeutics Business Overview Table 79. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 81. Partner Therapeutics Recent Development Table 82. Guangzhou Baiyunshan Pharmaceutical Company Information Table 83. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 84. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 86. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 87. Harbin Pharmaceutical Group Company Information Table 88. Harbin Pharmaceutical Group Business Overview Table 89. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 91. Harbin Pharmaceutical Group Recent Development Table 92. Hainan Unipul Pharmaceutical Company Information Table 93. Hainan Unipul Pharmaceutical Business Overview Table 94. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 96. Hainan Unipul Pharmaceutical Recent Development Table 97. North China Pharmaceutical Company Information Table 98. North China Pharmaceutical Business Overview Table 99. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 101. North China Pharmaceutical Recent Development Table 102. Amoytop Biotech Company Information Table 103. Amoytop Biotech Business Overview Table 104. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 106. Amoytop Biotech Recent Development Table 107. Changchun GeneScience Pharmaceutical Company Information Table 108. Changchun GeneScience Pharmaceutical Business Overview Table 109. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 111. Changchun GeneScience Pharmaceutical Recent Development Table 112. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 114. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2026) Table 115. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share Forecast by Country (2027-2032) Table 117. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country (2021-2026) Table 120. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share Forecast by Country (2027-2032) Table 122. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 124. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2026) Table 125. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country (2021-2026) Table 130. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country (2021-2026) Table 140. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share Forecast by Country (2027-2032) Table 142. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 144. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2026) Table 145. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country (2021-2026) Table 150. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country (2021-2026) Table 160. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List Table 165. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Image Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (2021-2032) & (US$ Million) Figure 4. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2021-2032) & (K Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inhalation Image Figure 8. Global Inhalation Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Type 2025 VS 2032 Figure 13. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type in 2025 Figure 14. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type in 2025 Figure 15. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cancer Treatment Support Image Figure 26. Global Cancer Treatment Support Sales YoY Growth (2021-2032) & (K Units) Figure 27. Infectious Disease Treatment Image Figure 28. Global Infectious Disease Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 29. Proteinosis Autoimmune Pulmonary Alveolar Image Figure 30. Global Proteinosis Autoimmune Pulmonary Alveolar Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Application 2025 VS 2032 Figure 35. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application in 2025 Figure 36. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application in 2025 Figure 37. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application in 2025 Figure 38. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application in 2025 Figure 41. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share in Value by Application in 2025 Figure 45. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Inhalation
  • Other
Applications
  • Cancer Treatment Support
  • Infectious Disease Treatment
  • Proteinosis Autoimmune Pulmonary Alveolar
  • Other
Companies covered
  • Nobelpharma
  • Partner Therapeutics
  • Guangzhou Baiyunshan Pharmaceutical
  • Harbin Pharmaceutical Group
  • Hainan Unipul Pharmaceutical
  • North China Pharmaceutical
  • Amoytop Biotech
  • Changchun GeneScience Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Inhalation
  8. 1.3.3 Other
  9. 1.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type
  10. 1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
  2. 2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers
  3. 2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges
  4. 2.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2026)
  2. 3.2 Global Top Players by Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2021-2026)
  3. 3.3 Global Top Players by Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (2021-2026)
  4. 3.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Major Company Production Sites & Headquarters
  6. 3.6 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Company, Product Type & Application
  7. 3.7 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Tier 1, Tier 2, and Tier 3
4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Regional Status and Outlook
  1. 4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Historic Market Size by Region
  3. 4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Forecasted Market Size by Region
  7. 4.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application
  1. 5.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Application
  2. 5.1.1 Cancer Treatment Support
  3. 5.1.2 Infectious Disease Treatment
  4. 5.1.3 Proteinosis Autoimmune Pulmonary Alveolar
  5. 5.1.4 Other
  6. 5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application
  7. 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Nobelpharma
  2. 6.1.1 Nobelpharma Company Information
  3. 6.1.2 Nobelpharma Business Overview
  4. 6.1.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  6. 6.1.5 Nobelpharma Recent Developments
  7. 6.2 Partner Therapeutics
  8. 6.2.1 Partner Therapeutics Company Information
  9. 6.2.2 Partner Therapeutics Business Overview
  10. 6.2.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  12. 6.2.5 Partner Therapeutics Recent Developments
  13. 6.3 Guangzhou Baiyunshan Pharmaceutical
  14. 6.3.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  15. 6.3.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  16. 6.3.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  18. 6.3.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  19. 6.4 Harbin Pharmaceutical Group
  20. 6.4.1 Harbin Pharmaceutical Group Company Information
  21. 6.4.2 Harbin Pharmaceutical Group Business Overview
  22. 6.4.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  24. 6.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 6.5 Hainan Unipul Pharmaceutical
  26. 6.5.1 Hainan Unipul Pharmaceutical Company Information
  27. 6.5.2 Hainan Unipul Pharmaceutical Business Overview
  28. 6.5.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  30. 6.5.5 Hainan Unipul Pharmaceutical Recent Developments
  31. 6.6 North China Pharmaceutical
  32. 6.6.1 North China Pharmaceutical Company Information
  33. 6.6.2 North China Pharmaceutical Business Overview
  34. 6.6.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  36. 6.6.5 North China Pharmaceutical Recent Developments
  37. 6.7 Amoytop Biotech
  38. 6.7.1 Amoytop Biotech Company Information
  39. 6.7.2 Amoytop Biotech Business Overview
  40. 6.7.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  42. 6.7.5 Amoytop Biotech Recent Developments
  43. 6.8 Changchun GeneScience Pharmaceutical
  44. 6.8.1 Changchun GeneScience Pharmaceutical Company Information
  45. 6.8.2 Changchun GeneScience Pharmaceutical Business Overview
  46. 6.8.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  48. 6.8.5 Changchun GeneScience Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country
  2. 7.1.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026)
  4. 7.1.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  6. 7.2.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026)
  8. 7.2.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country
  2. 8.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026)
  4. 8.1.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  6. 8.2.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country
  2. 9.1.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  6. 9.2.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country
  2. 10.1.1 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026)
  4. 10.1.3 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  6. 10.2.1 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026)
  8. 10.2.3 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country
  2. 11.1.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  6. 11.2.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Analysis
  2. 12.1.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process
  7. 12.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
  10. 12.2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst